DHC's Q3 Net Loss Widens Amid Soaring Impairment Charges

TL;DR

**DHC is bleeding cash and writing down assets, signaling deep trouble for its healthcare property portfolio.**

AI Summary

Diversified Healthcare Trust (DHC) reported a net loss of $164.04 million for the three months ended September 30, 2025, a significant increase from the $98.69 million net loss in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $264.67 million, an improvement from the $282.81 million loss in the prior year. Total revenues increased to $388.71 million for the quarter, up from $373.64 million, and to $1.16 billion for the nine months, up from $1.12 billion. However, total expenses surged to $497.90 million for the quarter, primarily due to a substantial increase in impairment of assets to $93.24 million from $23.03 million in Q3 2024. The company recorded $162.71 million in impairment charges for the nine months ended September 30, 2025, affecting 18 medical office and life science properties and 25 senior living communities. DHC generated $103.97 million in gain on sale of properties for the nine months ended September 30, 2025, compared to a $18.98 million loss in the prior year, driven by $353.68 million in property sales. Cash provided by operating activities plummeted to $492,000 for the nine months ended September 30, 2025, from $94.03 million in the same period of 2024, while cash provided by investing activities significantly improved to $276.15 million from a $120.88 million outflow.

Why It Matters

DHC's widening net loss and substantial asset impairments signal ongoing challenges in its real estate portfolio, particularly within its medical office, life science, and senior living segments. For investors, this indicates potential further erosion of asset values and continued pressure on profitability, making DHC a high-risk investment. Employees at these impaired properties may face uncertainty regarding their future. Customers, particularly residents in the senior living communities, could experience disruptions if properties are sold or operations are streamlined. In the broader market, DHC's struggles highlight the persistent headwinds in certain healthcare real estate sectors, potentially impacting valuations for competitors and the overall REIT market.

Risk Assessment

Risk Level: high — The company reported a net loss of $164.04 million for the three months ended September 30, 2025, and a significant increase in impairment of assets to $93.24 million for the quarter, up from $23.03 million in Q3 2024. For the nine months, impairment charges totaled $162.71 million, impacting 18 medical office and life science properties and 25 senior living communities, indicating substantial asset value erosion.

Analyst Insight

Investors should consider divesting DHC shares due to the persistent net losses, significant asset impairments, and a sharp decline in cash flow from operations. The company's strategy of selling properties to redeem debt, while necessary, suggests a distressed financial position.

Financial Highlights

debt To Equity

1.77

revenue

$1.16B

operating Margin

-12.7%

total Assets

$4.68B

total Debt

$2.72B

net Income

-$264.67M

eps

N/A

gross Margin

N/A

cash Position

$201.37M

revenue Growth

+3.8%

Revenue Breakdown

Key Numbers

• $164.04M — Net Loss (Q3 2025) (Increased from $98.69 million in Q3 2024)
• $264.67M — Net Loss (YTD Sep 2025) (Improved from $282.81 million in YTD Sep 2024)
• $93.24M — Impairment of Assets (Q3 2025) (Increased from $23.03 million in Q3 2024)
• $162.71M — Impairment of Assets (YTD Sep 2025) (Affected 18 medical office/life science and 25 senior living properties)
• $353.68M — Sales Price of Dispositions (YTD Sep 2025) (Generated $103.97 million gain on sale of properties)
• $492K — Cash Provided by Operating Activities (YTD Sep 2025) (Significantly decreased from $94.03 million in YTD Sep 2024)
• $276.15M — Cash Provided by Investing Activities (YTD Sep 2025) (Improved from a $120.88 million outflow in YTD Sep 2024)
• 242,146,962 — Common Shares Outstanding (As of November 3, 2025)
• $40.39M — Loss on modification or early extinguishment of debt (YTD Sep 2025) (Increased from $209,000 in YTD Sep 2024)
• $1.16B — Total Revenues (YTD Sep 2025) (Increased from $1.12 billion in YTD Sep 2024)

Key Players & Entities

• DIVERSIFIED HEALTHCARE TRUST (company) — Registrant in the 10-Q filing
• Nasdaq Stock Market LLC (regulator) — Exchange where DHC securities are registered
• AlerisLife Inc. (company) — Company in which DHC made an investment
• FASB (regulator) — Financial Accounting Standards Board
• SEC (regulator) — Securities and Exchange Commission
• Maryland (company) — State of incorporation for DHC
• Delaware (company) — State where DHC sold a Senior Living (SHOP) property
• California (company) — State where DHC sold Life Science properties
• Arizona (company) — State where DHC sold a Life Science property
• Connecticut (company) — State where DHC sold a Medical Office property

FAQ

Risk Factors

• Significant Impairment Charges [high — financial]: DHC recorded $162.71 million in impairment charges for the nine months ended September 30, 2025, impacting 18 medical office and life science properties and 25 senior living communities. This indicates a substantial decline in the value of these assets, potentially due to market conditions or operational challenges.
• Plummeting Operating Cash Flow [high — financial]: Cash provided by operating activities fell to $492,000 for the nine months ended September 30, 2025, a drastic decrease from $94.03 million in the prior year. This severe reduction raises concerns about the company's ability to generate cash from its core operations.
• Increased Debt and Interest Expense [medium — financial]: While total liabilities decreased slightly to $2.995 billion from $3.178 billion, secured debt and finance leases increased significantly to $455.85 million from $126.61 million. The company also incurred a $40.39 million loss on modification or early extinguishment of debt in YTD 2025, up from $209,000 in YTD 2024, indicating increased financing costs.
• Senior Living Market Volatility [medium — market]: The significant impairment charges affecting 25 senior living communities suggest ongoing challenges within this segment of the healthcare real estate market, potentially due to labor shortages, rising operating costs, or changing demand.
• Property Dispositions and Portfolio Realignment [medium — operational]: The company sold $353.68 million in properties year-to-date, generating a gain of $103.97 million. While this can improve portfolio quality, it also signifies a reduction in the asset base and potential impact on future revenue streams.
• Widening Quarterly Net Loss [high — financial]: The net loss for the three months ended September 30, 2025, was $164.04 million, a substantial increase from $98.69 million in the same period of 2024. This widening loss in the most recent quarter is a negative indicator.

Industry Context

Diversified Healthcare Trust operates in the healthcare real estate sector, which is sensitive to demographic trends, healthcare policy, and operational costs within senior living and medical office buildings. The sector faces challenges from rising labor costs, inflation, and evolving healthcare delivery models. Competitors may include other healthcare REITs and private real estate investors.

Regulatory Implications

Changes in healthcare regulations, reimbursement policies (e.g., Medicare/Medicaid), and zoning laws can significantly impact the profitability and operational viability of healthcare facilities. Compliance with health and safety standards is paramount and can incur substantial costs.

What Investors Should Do

1. Monitor operating cash flow trends closely.
2. Analyze the drivers of asset impairments.
3. Evaluate the impact of increased secured debt.
4. Assess the sustainability of the current dividend/distribution policy.

Key Dates

• 2025-09-30: Quarter and Nine Months Ended — Reporting period for the 10-Q, showing increased net loss for the quarter and improved net loss year-to-date, but a drastic drop in operating cash flow.
• 2025-11-03: Common Shares Outstanding — 242,146,962 shares outstanding, indicating a slight increase from the previous period.

Glossary

Impairment of assets

A reduction in the carrying value of an asset on the balance sheet when its fair value or recoverable amount falls below its book value. (A significant increase in impairment charges ($162.71M YTD) indicates potential overvaluation of assets or severe operational/market challenges affecting property values.)

Cash provided by operating activities

The net amount of cash generated from a company's normal business operations. (A dramatic decrease to $492K from $94.03M YTD signals a severe problem in the company's ability to generate cash from its core business.)

Gain (loss) on sale of properties

The profit or loss realized from selling real estate assets. (A substantial gain of $103.97M YTD from property sales ($353.68M in sales) is a key driver of the improved year-to-date net loss, but masks underlying operational cash flow issues.)

Senior unsecured notes

Debt instruments issued by a company that are not backed by specific collateral. (Represents a significant portion of DHC's debt ($1.58B as of Sep 30, 2025), and changes in its value or servicing costs impact financial health.)

Secured debt and finance leases

Debt that is backed by specific collateral or assets, or lease obligations treated as debt. (A significant increase in this category (to $455.85M from $126.61M) suggests new financing arrangements or acquisitions that require collateral.)

Year-Over-Year Comparison

Compared to the prior year, DHC reported higher total revenues for both the quarter ($388.71M vs $373.64M) and year-to-date ($1.16B vs $1.12B). However, total expenses surged, leading to a significantly wider net loss in the third quarter ($164.04M vs $98.69M), although the year-to-date net loss showed a slight improvement ($264.67M vs $282.81M). A critical concern is the dramatic drop in cash provided by operating activities to $492K from $94.03M year-to-date, while impairment charges more than tripled in the quarter and nearly quadrupled year-to-date.

Filing Documents

• dhc-20250930.htm (10-Q) — 2314KB
• dhc_093025xexhibitx101.htm (EX-10.1) — 7KB
• dhc_093025xexhibitx311.htm (EX-31.1) — 11KB
• dhc_093025xexhibitx312.htm (EX-31.2) — 11KB
• dhc_093025xexhibitx321.htm (EX-32.1) — 9KB
• 0001075415-25-000044.txt ( ) — 10152KB
• dhc-20250930.xsd (EX-101.SCH) — 61KB
• dhc-20250930_cal.xml (EX-101.CAL) — 72KB
• dhc-20250930_def.xml (EX-101.DEF) — 435KB
• dhc-20250930_lab.xml (EX-101.LAB) — 641KB
• dhc-20250930_pre.xml (EX-101.PRE) — 571KB
• dhc-20250930_htm.xml (XML) — 1649KB

Financial Statements (unaudited)

Financial Statements (unaudited) 1 Condensed Consolidated Balance Sheets — September 30, 2025 and December 31, 2024 1 Condensed Consolidated Statements of Comprehensive Income (Loss) — Three and Nine Months Ended September 30, 2025 and 2024 2 Condensed Consolidated Statements of Shareholders' Equity — Three and Nine Months Ended September 30, 2025 and 2024 3 Condensed Consolidated Statements of Cash Flows — Nine Months Ended September 30, 2025 and 2024 5 Notes to Condensed Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 48 Item 4.

Controls and Procedures

Controls and Procedures 50 Warning Concerning Forward-Looking Statements 51 53 PART II Other Information 54 Item 1A.

Risk Factors

Risk Factors 54 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 54 Item 6. Exhibits 54

Signatures

Signatures 56 References in this Quarterly Report on Form 10-Q to the Company, we, us or our include Diversified Healthcare Trust and its consolidated subsidiaries unless otherwise expressly stated or the context indicates otherwise. Table of Contents

Financial Information

PART I. Financial Information

Financial Statements

Item 1. Financial Statements. DIVERSIFIED HEALTHCARE TRUST CONDENSED CONSOLIDATED BALANCE SHEETS (dollars in thousands, except share data) (unaudited) September 30, December 31, 2025 2024 Assets Real estate properties: Land $ 542,403 $ 605,973 Buildings and improvements 5,416,972 5,817,279 Total real estate properties, gross 5,959,375 6,423,252 Accumulated depreciation ( 2,077,012 ) ( 2,082,777 ) Total real estate properties, net 3,882,363 4,340,475 Investments in unconsolidated joint ventures 112,769 126,859 Assets of properties held for sale 258,389 276,270 Cash and cash equivalents 201,371 144,584 Restricted cash 8,252 5,270 Equity method investment 8,240 24,590 Acquired real estate leases and other intangible assets, net 21,784 26,300 Other assets, net 190,806 192,657 Total assets $ 4,683,974 $ 5,137,005 Liabilities and Equity Secured revolving credit facility $ — $ — Senior secured notes, net 687,487 826,974 Senior unsecured notes, net 1,580,027 1,957,319 Secured debt and finance leases, net 455,851 126,611 Liabilities of properties held for sale 17,604 6,024 Accrued interest 12,408 23,092 Other liabilities 241,867 238,142 Total liabilities 2,995,244 3,178,162 Commitments and contingencies Common shares of beneficial interest, $ .01 par value: 300,000,000 shares authorized, 242,146,962 and 241,271,703 shares issued and outstanding, respectively 2,421 2,413 Additional paid in capital 4,622,061 4,620,313 Cumulative net income 1,143,358 1,408,023 Cumulative other comprehensive income (loss) 19 ( 17 ) Cumulative distributions ( 4,079,129 ) ( 4,071,889 ) Total equity 1,688,730 1,958,843 Total liabilities and equity $ 4,683,974 $ 5,137,005 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 Table of Contents DIVERSIFIED HEALTHCARE TRUST CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (amounts in thousands, except per share data) (unaudit

View Full Filing

View this 10-Q filing on SEC EDGAR